Clinical autonomy
Local owners retain diagnosis, treatment planning, material and laboratory choice, referrals, scheduling philosophy, staffing judgment, and patient communication within law and professional duties.
Independent scale · Governance
“Independent,” “cooperative,” “GPO,” “network,” “IPA,” and “shared services” are labels. They do not prove member control, clinical autonomy, lawful conduct, security, fairness, or an easy exit.
Proposed public charter
Local owners retain diagnosis, treatment planning, material and laboratory choice, referrals, scheduling philosophy, staffing judgment, and patient communication within law and professional duties.
Eligibility, voting, board authority, reserved powers, amendments, removal, conflicts, and dissolution must be defined before members commit.
Vendor selection, fees, rebates, sponsorships, referrals, paid placement, data value, and complaint handling must be public.
Collect only what the defined service requires; publish use, access, sharing, retention, deletion, audit, incident, and portability rules.
No competitor fee coordination, boycott, allocation, or identifiable current/future competitive strategy exchange.
Members can understand term, termination, surviving obligations, data export, open work, credentials, vendor transition, and continuity before joining.
Claims, benchmarks, vendor records, and service results carry source, period, denominator, limitation, correction, and review status.
Education is not operational authorization. Each new service clears legal, governance, privacy, security, operational, financial, and member-demand gates.
Current red lines
Why the antitrust language changed
DOJ withdrew three healthcare antitrust policy statements in February 2023. The FTC withdrew two corresponding statements in July 2023. FTC and DOJ then withdrew the 2000 competitor-collaboration guidelines in December 2024.
In February 2026, the agencies opened a public inquiry about potential updated business-collaboration guidance. An inquiry is not final guidance, an advisory opinion, or permission for a particular purchasing, data, payer, or network structure.
DenQAI therefore presents a clearly labeled hypothetical ideal: member control, clinical autonomy, commercial transparency, minimum necessary data, independent competitive decisions, measurable value, complaint and correction rights, and an orderly exit. Specialized counsel must still design and review the actual activity, market, participants, information, contracts, governance, training, monitoring, and enforcement.
Launch gate
A defined member problem is observed, material, and not solved adequately by education or a local file.
Ownership, voting, board, management, reserved powers, conflicts, and eligible participants are documented.
Specialized counsel reviews antitrust, health, professional, corporate, privacy, employment, contracting, and state issues.
Fees, rebates, sponsorship, vendor selection, complaints, ranking, and independence rules are public.
Minimization, identity, authorization, encryption, logging, retention, deletion, incident, backup, recovery, and testing are implemented.
Service levels, competence, exceptions, corrections, continuity, vendor failure, and member support are tested.
A member can export records, transfer open work, revoke access, and leave without clinical disruption.
Demand without sensitive data
The current interest brief stays on your device and does not collect contracts, pricing, patient data, or transaction records.
Build an interest brief